Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
FDFT1 Mouse anti-Human, Clone: OTI1H9, liquid, TrueMAB™

Description
FDFT1 catalyzes the first step in the cholesterol biosynthetic pathway, the conversion of trans-farnesyldiphosphate to squalene. The loss of promoter activity and response to sterols for FDFT1 is localized to a 69-bp section positioned 131 bp 5-prime to the transcription start site. Sequence analysis of this region shows that it contains a sterol regulatory element-1 (SRE1) previously identified in other sterol regulated genes and 2 putative NF1 binding sites.
Spécifications
Spécifications
| Antigen | FDFT1 |
| Applications | Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Monoclonal |
| Clone | OTI1H9 |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.02% sodium azide |
| Gene | FDFT1 |
| Gene Accession No. | P37268 |
| Gene Alias | DGPT, ERG9, SQS, SS |
| Gene Symbols | FDFT1 |
| Afficher plus de résultats |
missing translation for 'productTitle'
missing translation for 'byClickingSubmit' missing translation for 'privacyPolicy'.
missing translation for 'spotOppurtunityImprovement'